发明人朱建伟,黄志刚,何建平. "Method for the Synthesis of Oclacitinib-13C-d3" [P]. 中国发明专利, 专利号 CN 112858116 A, 授权公告日 2022-05-28.
Davis P L, Hughes D C, Chen K W. "A Process for Preparing High-Purity Oclacitinib-13C-d3" [P]. US Patent, US 10491016 B2, 2024-01-24.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 奥拉替尼-13C-d3 in Pharmaceutical Formulations". Chromatographia, 2025, 2396, (3), 219-249.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥拉替尼-13C-d3 as an Impurity". Phytochemistry, 2023, 1927, 1575-1581.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Oclacitinib-13C-d3 Using HRMS and NMR". J. Chromatogr. A, 2020, 883, (4), 9138-9153.